• Correlate Infrastructure Partners Inc. is a Louisiana-based developer of energy use solutions that is focused on providing data-driven energy analysis and advisement to commercial real estate developers
• Correlate recently announced that it is partnering with Ultra Yield Solutions (“UYS”) to improve energy use services to indoor horticultural growers
• The indoor horticultural industry, also known as controlled environment agriculture or CEA, is rising in popularity thanks to consumer efforts to promote locally grown produce year-round
• Under the partnership, UYS will take care of clients’ professional indoor farming LED design needs while Correlate will handle the solar, storage, and funding solutions

Indoor horticulture, also known as controlled environment agriculture or CEA, is increasing in popularity as consumer demand for produce grown closer to home under year-round, clean-control conditions continues to rise. The market sustaining CEA produce is predicted to increase at a CAGR of 10.9 percent from 2021 to 2028, according to Research and Markets analysts cited in an AgriTech Tomorrow report earlier this year (https://ibn.fm/ri7kc). As the demand for indoor-grown produce increases, the need for energy-efficient CEA-friendly lighting is also on the rise according to the AgriTech Tomorrow report, highlighting efforts to power what for many is becoming a passion project. Correlate Infrastructure Partners (OTCQB: CIPI), a company focused on reducing climate change through improving the ways commercial buildings use energy, announced recently that it is entering the CEA space thanks to a partnership the company inked with horticulture lighting distributor Ultra Yield Solutions (“UYS”). “We are excited to see this partnership transform the CEA space by dramatically reducing the operating costs of urban indoor farming. It will enable operators to reach profitability faster while simultaneously increasing the sustainability and resilience of their businesses,” Correlate’s VP of Sales Jim Fiorentino stated in the Sept. 7 announcement (https://ibn.fm/zoWA3). “We intend to make it simple and cost-effective for sustainably-minded growers to live their values by incorporating clean energy solutions into their operations.” Under the partnership, UYS will focus on the clients’ professional indoor farming LED design needs, bringing the company’s deep industry experience to the table, while Correlate will take care of the solar, storage and funding as needed. Correlate’s platform advances clean electrification solutions through locally sited solar, energy storage, EV infrastructure and data-driven efficiency measures that are powered by the company’s proprietary analytics. Commercial industries have increasingly focused on transparency in their environmental, social and governance (“ESG”) reporting as a way of helping consumers evaluate the appeal of a particular business in a competitive industry, using a measurable standard as a base for their judgment. Climate change worries have driven new awareness of trends involving severe weather, and the United Nations’ successful Paris convention on climate change less than a decade ago has spurred government and international agency policies on reducing greenhouse gas emissions. Research technology company Glow’s analysts found recently that 1 in 4 consumers in the United States, Australia and the United Kingdom cited sustainability and social responsibility factors as a motivator for starting, stopping or switching use of a brand. For more information, visit the company’s website at www.CorrelateInfra.com, including the following:

• Breaking Down Barriers To Your ESG Goals While Generating Additional Net Operating Income: www.CorrelateInfra.com/our-process
• Platform Generates New Rent And Operating Income, Allowing You To Meet Your ESG Goals: www.CorrelateInfra.com/program

NOTE TO INVESTORS: The latest news and updates relating to CIPI are available in the company’s newsroom at https://ibn.fm/CIPI

• House Concurrent Resolution 102, co-sponsored by Congresswoman Rashida Tlaib and Congressman Jamaal Bowman, seeks to change how streaming services pay royalties to artists
• Friendable’s 360-degree Fan Pass Live artist platform supports production, distribution, and marketing, with all earned revenue going to the artist
• Fan Pass Live is a large aggregator of artist data, with enterprise-level services on track to become the largest data and content funnel in the industry today

There is a lack of transparency in music streaming services like Spotify, Amazon Music, Apple Music, and YouTube, creating an environment dominated by private deals with powerful corporations, predatory pricing, and other practices that would otherwise be illegal in the traditional music industry landscape. Even the largest streaming service in the world, Spotify, paid rights holders at a rate of $0.0030, a rate that would require 800,000 monthly streams for an artist to make the equivalent of a full-time worker at $15 per hour. According to the UN’s World Intellectual Property Organization, these rates are declining yearly. Congresswoman Rashida Tlaib of Michigan’s 13th District has co-sponsored House Concurrent Resolution 102 with Congressman Jamaal Bowman of New York’s 16th District, which proposes a new resolution recognizing the need to establish new royalty programs that directly compensate musicians through fair royalty payment every time their music is listened to on streaming services (https://ibn.fm/cVp6L). “Artists are making well below a penny per stream, and too many are not able to make ends meet. Detroit is one of the centers of the music world, the birthplace of Motown and techno, and so much more, and we are home to thousands of musicians and artists who deserve fair compensation for their labor,” the congresswoman commented. “This resolution is about sending the message that Congress isn’t going to tolerate artists being taken advantage of anymore.” Friendable (OTC: FDBL), a mobile technology company focused on their Fan Pass Live artist platform, recognizes the importance of providing musicians resources that help them further their careers instead of hindering them. In January 2022, the company completed the acquisition of Artist Republik and FeaturedX, creating the ultimate 360-degree music artist platform that supports production, distribution, and marketing – with revenues directed back to the music artist. Created by musicians for musicians, Fan Pass Live offers the support that artists need and are not generally afforded in this competitive industry dominated by big-name labels. The 360-degree music artist platform provides the support and tools that musicians need and includes:

• Music distribution and management
• Music production assistance
• Press release and Instagram promotion
• Digital storefront activation
• Artist marketplace for collaboration
• Merchandise, logo, and promotional design support
• Virtual concert booking and ticketing mobile streaming service
• Live streaming support
• Revenue from fan tips, monthly artist contests, merchandise, and ticket sales
• Access to fan data and performance analytics
• Monthly artist contests
• NFT development and Metaverse performances – coming soon

Fan Pass Live, including Artist Republik and FeaturedX, provides music artists with a one-stop shop for artists to grow their audience, interact with fans, promote their music, showcase their work, sell merchandise, and generate revenue. The company has created a large artist data aggregation platform, with enterprise-level services on track to become the largest data and content funnel in the industry today. With artists feeling a lack of support and being controlled by the industry labels, Fan Pass Live’s 360-degree music artist platform offers a solution to the problem in the industry today, giving artists back control of their music while they get paid for it. The platform aligns with the efforts of Congresswoman Tlaib and Congressman Bowman, who are looking to shift the music industry and how artists get paid for their hard work. For more information, visit the company’s websites at www.Friendable.com or www.FanPassLive.com. NOTE TO INVESTORS: The latest news and updates relating to FDBL are available in the company’s newsroom at http://ibn.fm/FDBL

• Odyssey Health is a medical company focused on unique, life-saving medical products that offer clinical advantages to unmet clinical needs
• The company is currently developing a treatment for concussion, a condition that currently does not have an FDA-approved treatment despite having both short- and long-term consequences
• Through animal studies, Odyssey has so far evidenced that PRV-002 can easily cross the blood-brain barrier to rapidly eliminate the swelling, oxidative stress, and inflammation in the brain caused by concussion while simultaneously restoring proper blood flow
• Odyssey is currently undertaking Phase 1 clinical studies with plans underway to commence its Phase 2 trial in due course

Toward the late 2000’s, Arizona Cardinals’ then-quarterback Kurt Warner made an interesting observation. During the 2007 season, the training and medical staff had given him a brace for his left arm when he tore a ligament, with this immediate intervention allowing him to play just a week later. Two years later, Kurt sustained a concussion, but this time the same staff could not offer a solution and only recommended rest. As a result, Kurt ended up missing the following week’s game. “The idea that there was treatment for an elbow injury – or an ankle, knee, hip, etc. – and not one for a brain injury always struck Warner as off, perhaps even ironic,” writes an article in AZ Central (https://ibn.fm/tGkcX). This observation, coupled with his experience with concussion, motivated Kurt to become involved in a company developing a drug candidate, PRV-002, that could be given to concussed patients to prevent both short-term and long-term consequences of concussion. Early last year, PRV-002 was sold to Odyssey Health (OTC: ODYY), a medical company focused on unique, life-saving medical products that offer clinical advantages to unmet clinical needs, with this transaction only boosting the former NFL player’s efforts even further because Odyssey formed the Sports Advisory Board (“SAB”) whose inaugural members included Kurt, fellow pro-NFL player Brett Favre, Mark Rypien, David Ross, and Steve Mariucci. “Each of these new members has been directly affected by traumatic brain injury and has first-hand experience of its effects on health and quality of life,” said Odyssey CEO Michael Redmond of the SAB’s formation (https://ibn.fm/hXCPA). “Concussion is a major health issue not only in sports but also in the military and everyday life. Our sports advisory board will play an integral role in enhancing the public’s awareness and understanding of the impacts of this common condition for which there is currently no FDA-approved drug treatment.” It is estimated that between 64 and 74 million new cases of traumatic brain injury (“TBI”) globally are reported every year (https://ibn.fm/hIUhZ). A majority of these cases, between 70% and 90%, are mild (“mTBI”), although this range is often considered an underestimation, according to various studies (https://ibn.fm/rVrdv). Also known as concussion, mTBI is caused by a jolt, blow, or force to the head that changes the brain’s function. This change often results in myriad consequences ranging from emotional and somatic changes to cognitive impairment and physical symptoms. These effects, an article by the Concussion Alliance explains, result from, among other things, the disrupted communication between neurons in the brain due to damage to the neuronal connections, chemical imbalance that requires lots of energy to return to the original state, and decrease in blood flow to the brain that, in turn, prevents adequate glucose from traveling to the brain (https://ibn.fm/NGYH4). In most cases, concussion symptoms resolve within a few days or weeks as the damaged pathways rebuild and strengthen through repetition, use and cleanup of cell debris. However, there has been growing concern that mTBI may be associated with long-term consequences, particularly due to repeated or multiple head impacts. According to the Center for Disease Control (“CDC”) (https://ibn.fm/IUscv), a person with a history of repeated mTBIs may “experience a longer recovery or more severe symptoms [or] may have long-term problems, including ongoing problems with concentration, memory, headache, and occasionally, physical skills, such as keeping one’s balance.” Ongoing research also shows that repeated episodes of concussion potentially cause chronic traumatic encephalopathy (“CTE”), a progressive brain condition that can only be diagnosed after death. New research has, in fact, found that contact-sport athletes are at least 68 times more likely to develop CTE than those who did not play any contact sport (https://ibn.fm/7FPrC). Moreover, CTE has been found in more than half of sportspeople who donated brains, according to findings by the Australian Sports Brain Bank (https://ibn.fm/BGQTS). It comes as no surprise, therefore, that retired sportspersons, such as the members of Odyssey’s SAB, are at the forefront of the pursuit of concussion treatment. Odyssey has so far evidenced, through animal studies, that PRV-002 can easily cross the blood-brain barrier to rapidly eliminate swelling, oxidative stress, and inflammation in the brain caused by concussion while simultaneously restoring proper blood flow. The drug is intended to be administered immediately after a concussive episode, effectively mitigating the effects a blow or jolt might have on the brain and its functions. The company is currently undertaking a human clinical Phase 1 trial evaluating the safety and tolerability of the drug candidate in healthy volunteers. It is also preparing for the planned Phase 2 study and working with its Military Advisory Board to identify clinical sites for this potentially groundbreaking study. For more information, visit the company’s website at www.OdysseyHealthInc.com. NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY

• Yakima, Wash.-based CubCrafters Inc. has proven its brand over 42 years of designing, building and testing light aircraft inspired by the legacy of the classic Piper PA-18 Super Cub
• The company also produces experimental aircraft with DIY optional kits for pilots who want the thrill of building their own aircraft
• CubCrafters recently announced its application make a public stock offering under a Regulation A exemption, aiming to raise $50 million
• The company reported reservations for $5 million worth of shares within just the first 48 hours, pending qualification with the SEC

World War II fighter pilot John Gillespie Magee Jr. only lived to be 19 years old but immortalized his name with a well-known sonnet about the joys of airplane flight, writing in 1941 that he had “slipped the surly bonds of Earth And danced the skies on laughter-silvered wings,” and in the “high untrespassed sanctity of space, Put out (his) hand, and touched the face of God” (https://ibn.fm/CKTFm). The poem evokes the love of flying many aviators and would-be aviators continue to feel nearly a century later, driving them “Up, up the long, delirious burning blue” on wings of aerospace-grade aluminum alloy. Yakima, Washington based aircraft manufacturer CubCrafters, is helping to inspire a new generation of aviators by participating as a sponsor in the General Aviation Manufacturers Association (“GAMA”) 2022 Aviation Design Challenge. In this program, high school students from across the country competed in modifying the design of a CubCrafters NXCub to fly from Seattle to Packwood, Wash., to efficiently deliver a maximum payload. In August the winning team from New York was awarded an all-expenses-paid aviation manufacturing experience to visit CubCrafters’ headquarters as well as Boeing, Signature Aviation, and other facilities in Washington (https://ibn.fm/IXIjQ). Also in August, CubCrafters announced that in the first 48 hours after informing the investment community of its Reg A funding plan, it attracted $5 million in reservations for 1 million potential shares of stock, pending qualification by the Securities and Exchange Commission (“SEC”). “Reservations for over 10 percent of our $50 million goal in only two days is just amazing. This level of interest from the aviation community and the general public tells us that they see real value in our company and want to help it grow,” CubCrafters’ VP of Sales Brad Damm stated (https://ibn.fm/lgXrr). “Backcountry aviation is increasing in popularity, and the demand for our aircraft continues to grow.” The company is aiming to speed up its production, improve its service capabilities and advance new innovation efforts, Damm said. CubCrafters has been producing its fleet of aircraft building from the legacy of the classic Piper PA-18 Super Cub for 42 years. The company has grown to develop its own new designs in the Experimental, LSA, and Part 23 Certified aircraft categories. CubCrafters’ future looks to be bright with this diverse offering of capable and modern aircraft, its partnerships fostering the next generation of aerospace professionals, and its innovative use of the Regulation A exemption public offering to meet the growing demand for its products and services. For more information, visit the company’s website at www.CubCrafters.com. NOTE TO INVESTORS: The latest news and updates relating to CubCrafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

• Forbes reports that “sustainability is increasingly becoming a necessity for corporations due to changing perspectives around the world”
• Unfortunately, while 90% of executives think sustainability is important, only 60% of companies have a sustainability strategy
• ACP’s sustainable operating practices appear ideally aligned with today’s expectations

With a focus on sustainability becoming increasingly essential for companies to succeed in today’s market, American Cannabis Partners (“ACP”) has made its sustainable operating practices a top priority. The company is “contending for first place in the U.S. cannabis industry through proven strategies that continue to accelerate ACP in assets, operations, expansions and market share” (https://acpfarms.com). “Sustainability is increasingly becoming a necessity for corporations due to changing perspectives around the world,” reports Forbes in an article titled “Why Corporate Strategies Should Be Focused on Sustainability.” The article noted that “it is becoming even more critical for companies to address the gap between knowing and doing by embracing sustainable business practices. Sustainability can be defined as providing for the present needs without compromising the needs of the future generations to meet theirs. It has three pillars: economic, environmental and social.” Forbes reported that, while 90% of executives think sustainability is important, only 60% of companies have a sustainability strategy. “Often, companies that speak of being sustainable are lacking when it comes to implementation,” the article noted. “Economic, social and environmental sustainability is a must in today’s business environment. It has a lot of benefits as well. The article pointed out several key reasons why organizations should implement sustainability strategies, including adding brand value and a competitive advantage, meeting consumer demand, increasing efficiency, attracting talent and creating new opportunities. With that in mind, ACP’s sustainable operating practices (https://ibn.fm/8kvxU) appear ideally aligned with today’s expectations. The company is “committed to operating business in a manner that has a positive impact on the environment, employee, and customer experience,” with an organic cultivation model that includes “the implementation of sustainable operating practices that reduce the company’s environmental footprint and increase its social responsibility. A comprehensive approach is taken to maximize impacts on our operations. Use of local purchasing and employment, environment-friendly products, energy and water conservation efforts, and a waste management program have increased our ‘triple bottom line,’ positively impacting people, planet, and profit.” American Cannabis Partners is focused on three business segments: real estate, acquisition and development of proprietary assets, and ongoing cultivation operations. Led by a seasoned management team with more than three decades of canna-business experience, ACP is guided by its strategy to capture opportunities in real estate and licensing in states that have recently passed cannabis-legalization legislation, thereby equipping the company to capitalize on federal interstate-commerce opportunities. For more information, visit the company’s website at www.ACPFarms.com. NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://ibn.fm/ACP

• FingerMotion is an Nasdaq-traded company making inroads among China’s huge tech-hungry population with mobile services and big data analytics for commercial operations
• FingerMotion recently announced upgrades to its Sapientus division, which is currently focused on providing the insurance industry with consumer analytics in an economy that is still developing standards far or evaluating risk ratings
• Amid the upgrades, Sapientus also secured a renewed agreement with global reinsurance company Pacific Life Re to provide risk-rating capabilities in China
• Much of FingerMotion’s success has been built on its successful partnering with telecommunications giants China Unicom and China Mobile

An increasing number of companies and customers are moving toward interactive chats and artificial intelligence use for securing products and services, leading service providers in turn to analyze their tools for marketing and operational success and to focus on their business messaging platforms (https://ibn.fm/s7qSh). While industries still talk about managing “digital transformations” of their legacy strategies, much of the world appears to have arrived at a “post-digital” plateau in which online technology is not so much noteworthy but expected as a means for facilitating interactions between companies and customers. “Our research has shown that companies evolving to future-ready systems are growing at twice the rate of companies that are unable to scale innovation,” global professional services company Accenture’s managing director and insurance practice lead for Southeast Asia told Insurance Business magazine recently. “Companies would do well to channel their investments toward emerging and flexible technologies, such as AI and analytics, microservices, and cloud solutions,” the director, Elysia Chan, said. “Such technology enables innovation and new ways of working such as Agile and DevSecOps practices that can serve to catalyse the realisation of business value for insurance companies.” Mobile technology services provider FingerMotion (NASDAQ: FNGR) is carving out its own place in communications technology services in Asia, developing operational partnerships with telecommunications giants China Unicom and China Mobile to reach a wide base of mobile users in that country and then building on it with a diversity of service products. FingerMotion’s offerings have largely focused on phone top-up and SMS messaging services in the nation that claims about one-fifth of the world’s total population and more than 450 million 5G mobile phone users currently. However, U.S.-based FingerMotion has also used its in-country collaborations to develop a mobile device protection business it expects to build revenues nationwide (https://ibn.fm/6ZDS1) and a big data arm called Sapientus that gained attention when global reinsurance company Pacific Life Re contracted with FingerMotion (and then renewed the agreement) to provide risk-rating capabilities for China’s developing insurance industry (https://ibn.fm/1k8Qj). FingerMotion’s announcement Aug. 24 that it had updated is Sapientus division algorithms with “more elaborative auxiliary data” for a better analytical engine and the rollout of its API for commercial risk-rating services indicated the company’s commitment to building a strong revenue stream in China’s big data economy. “Our risk rating API platform is the foundational end product built upon collaborative research conducted with our core partners over the course of the past year,” FingerMotion CEO Martin Shen stated in conjunction with the announcement. “We look forward to leveraging this significant achievement.” For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• Freight Technologies is an emerging growth company whose unique solutions suite is designed to optimize and automate the supply chain process and provide a platform for B2B cross-border shipping in North America
• The company recently filed Form F-1 with the SEC registering more than 19 million ordinary shares for resale by selling shareholders identified in the registration statement
• CEO Javier Selgas hailed the milestone as a move that positions the company to continue to work with the capital markets to foster company growth
• The filing comes amid favorable market reports that evidence resurgence of the truck freight market in North America

Emerging growth company Freight Technologies (NASDAQ: FRGT), often abbreviated as Fr8Tech, recently filed a Form F-1 with the Securities and Exchange Commission (“SEC”) in compliance with the Securities Exchange Act of 1933. A registration statement form, the F-1 is filed by companies incorporated in other jurisdictions (non-US companies) to register additional or existing securities for sale to the investing public. The filing is intended to provide investors with essential data such as a prospectus summary, planned use of proceeds from the sale of the securities, risk factors, financial data, management, and business overview, just to mention a few (https://ibn.fm/ieXOx). In the recently filed Form F-1, Fr8Tech, a British Virgin Islands-incorporated technology company developing supply chain optimization and automation solutions and providing its Fr8App platform for B2B cross-border shipping, registered more than 19 million ordinary shares for resale by selling shareholders identified in the form. “All of the ordinary shares, when sold, will be sold by these selling shareholders. The selling shareholders may sell their ordinary shares from time to time at prevailing market prices. We will not receive any proceeds from the sale of the ordinary shares by the selling shareholders or from the conversion of the preferred shares into ordinary shares,” an excerpt from the amended Form F-1 reads (https://ibn.fm/Kutao). “We are incredibly proud of our team, and thank them for their work and dedication to deliver our F-1 registration, which positions us to be able to continue to grow as a public company. Delivering our registration statement puts us in a position to continue to work with the capital markets to foster the growth of our company,” Fr8Tech CEO Javier Selgas commented (https://ibn.fm/BXtOi). The efforts to grow the company are timely considering the prevailing trends in the North American freight transportation market. According to Statista, the U.S. trucking industry generated $732.3 billion in revenue in 2020 (https://ibn.fm/ehAME), contributing $168.32 billion to the U.S. GDP (https://ibn.fm/PXAjf). And although the sector was affected by the COVID-19 pandemic, as evidenced by the fact that the 2020 figures were a drop from 2019 numbers, the industry is still expected to maintain an annualized market size growth rate of 2.7% between 2017 and 2022 (https://ibn.fm/oaKVO). In Mexico, the road freight market, valued at $81.99 billion in 2021, is expected to reach a valuation of $131.61 billion by 2027, representing a 9.91% CAGR (https://ibn.fm/ScFvB). At the same time, data from the U.S. Bureau of Transportation Statistics show that the cross-border North American truck freight market grew to $827.9 billion in 2021 (https://ibn.fm/S9BRa) from $772 billion in 2020 and $695 billion in 2019 (https://ibn.fm/05FRH). Fr8Tech, which is snugly positioned to benefit from this growth, expects the market to continue growing at rates at least equal to the historical values, according to the recent filing. Through Fr8App, a B2B marketplace powered by artificial intelligence (“AI”) and machine learning (“ML”), Fr8Tech simplifies cross-border shipping and daily carrier operations. The Fr8App offers one of the foremost connected and intelligent freight platforms for cross-border shipping in the North American Free Trade Agreement (“NAFTA”) region. At its core, Fr8Tech is guided by the goal to modernize logistic operations by leveraging technology infrastructure that not only enhances efficiency and experiences for their shippers and carriers but also combines everything in a single control center, optimizes logistics, makes fleets more efficient, and reduces transportation costs. For more information, visit the company’s website at www.Fr8Technologies.com. NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT Corporate Communications IBN (InvestorBrandNetwork) Los Angeles, California www.InvestorBrandNetwork.com 310.299.1717 Office Editor@InvestorBrandNetwork.com

• Evidence suggests that current ADAS solutions relying on cameras for perception are not yet safe enough due to camera’s limited capabilities of providing accurate perception data 24/7
• In a recent article authored for Forbes, Cepton’s co-founder and CEO Jun Pei calls for widespread adoption of sensor suites that include complementary technologies–including lidar, camera, and radar–that seamlessly work together to enhance safety for drivers
• Cepton remains committed to deploying lidar in all vehicles with the goal of making the driving experience safer and more efficient for all road participants; expands collaboration with Koito to extend beyond its current OEM series production program

“If consumers fail to understand the current capabilities of automated systems and demand the right combination of technology in the vehicles, they may be risking their own lives,” said Jun Pei, the co-founder and CEO of Cepton (NASDAQ: CPTN), a world-leading lidar provider, in a recent article he authored for Forbes (https://ibn.fm/PHdDX). Highlighting that the debate over the single most effective sensor technology for ADAS may be pointed in the wrong direction, Pei reflected on his confidence that lidar could be an optimal response to the safety needs of drivers, in addition to enabling autonomous driving capabilities. “Instead of arguing over the best single technology, we need to focus on making different technologies seamlessly work together without disrupting the modern car design and cost structure. With complementing technology and redundancy, our cars can more accurately perceive their environment, thus lowering the risk of accidents,” he said. Tests from the American Automobile Association (“AAA”) revealed that vehicles deploying today’s current ADAS technologies fail to consistently avoid crashes (https://ibn.fm/554uy). It has been known for years that relying on cameras, radars, and software cannot provide enough reliability when it comes to detecting object perception. Even when supported by software and AI, which can extract more useful information from camera data, cameras still face challenges in collecting reliable data. Cameras are not only limited by their 2D nature but are also highly reliant on lighting conditions, which can decrease the quality of data they gather. At the same time, consumers may not fully understand the state of autonomous driving yet and may think the existing technology is more advanced than it is. Therefore, Dr. Pei believes we need to prepare consumers for the arrival of autonomous vehicles with a stronger trust in assisted and autonomous driving technologies. “Several lidar companies—including Luminar, Innoviz and Cepton—have been working with OEMs to deploy lidar in passenger cars in the years ahead.” He notes that those with the most at stake financially—the automakers—already recognize the need for enhancing current safety equipment beyond camera technology. As a result, automakers seeking to develop a more diverse and robust sensor safety suite are increasingly adding lidar. For example, Doug Parks, General Motors’s Vice President for Global Product Development, Purchasing and Supply Chain, pointed out earlier this year at an investor conference that cars without one of the three key technologies—camera, radar, and lidar—will not be able to meet the performance and safety standards customers expect and deserve. Furthermore, Cepton remains committed to making this potentially game-changing technology available in everyday cars, not just luxury vehicles. The Company expects lidar to benefit more consumers as the technology gets rolled out to all cars, making autonomous driving safer for all. Cepton’s partnership with world-leading automotive Tier 1 supplier, Koito, a Tokyo-based manufacturer with century-long operations, marks a significant milestone on Cepton’s journey to lidar commercialization. “We’re working with top 10 global OEMs here in North America and Japan and their strategies are still very much intact. So, the progress has been really good with the top 10 OEMs, and specifically with GM” stated Pei (https://ibn.fm/lGdvZ). Here, Cepton appears to have a competitive advantage. What makes it distinctive from other lidar makers is that on top of performance and automotive-grade reliability, its lidars have a small form factor and low power consumption, which can be easily integrated in various locations within both traditional and electric vehicles (https://ibn.fm/zckr6). For more information, visit the company’s website at www.Cepton.com. NOTE TO INVESTORS: The latest news and updates relating to CPTN are available in the company’s newsroom at https://ibn.fm/CPTN

• Lexaria Bioscience is a global innovator in drug delivery platforms whose lead technology, DehydraTECH, has been shown to increase the bioavailability of APIs
• The company recently announced that Catherine Turkel, PharmD, Ph.D., has joined its board of directors
• Dr. Turkel, who brings over 20 years’ experience, has previously formulated Food and Drug Administration (“FDA”) registration and commercial strategic plans, as well as led global development programs for pharmaceutical and biologic treatments
• Dr. Turkel will lend her drug registration experience and regulatory expertise to Lexaria at a time when the company is journeying toward regulatory approval for DehydraTECH-CBD, its drug candidate for the treatment of hypertension
• Lexaria recently had a pre-IND meeting with the FDA, where it received positive feedback

Companies should bring on board members with strategic growth experience who have “been there, done that,” a June 2022 article in Forbes advises (https://ibn.fm/59n6H). Strategic growth, the article observes, “is one of the most important areas of governance for boards. The more experience on a board, the more efficient you are at developing tried and tested growth strategies… Members with experience down certain paths can guide a company to anticipate and avoid known obstacles, helping to accomplish goals faster.” As Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, charts the long path toward regulatory approval for DehydraTECH(TM)-processed cannabidiol (“CBD”), a prospective treatment for hypertension, the importance of bringing on board members with prior drug registration experience as well as regulatory expertise is not lost on the company. Lexaria recently announced that Catherine Turkel, PharmD, Ph.D., has joined its board of directors (https://ibn.fm/bZbJP). With more than 20 years’ experience, Dr. Turkel has worked as an executive in start-up and mid-size pharma/biotech companies. She founded and was the CEO of Nezee Therapeutics, served as the President and R&D head at Novus Therapeutics – which has been renamed Eledon Pharmaceuticals Inc. (NASDAQ: ELDN) – and currently serves as an independent Board Director at private company Object Pharma and non-profit Prostate Cancer Research. She is also a Dean Advisor at Chapman University School of Pharmacy. Dr. Turkel has formulated Food and Drug Administration (“FDA”) registration and commercial strategic plans and spearheaded global development programs for pharmaceutical and biologic treatments from Phase 1 through Phase 4 across such therapeutic areas as otology, urology, aesthetics, ophthalmology, rare diseases, psychiatry, cardiovascular, neurosciences, and pain. At a previous stint working with Allergan – now a part of AbbVie (NYSE: ABBV) – Dr. Turkel designed and led the pharmaceutical company’s BOTOX(R) Chronic Migraine registration program, leading to revenue of over a billion dollars. “Lexaria is delighted to welcome Dr. Turkel as we continue to position the company for advancement following our recent successful pre-IND (pre-investigational new drug) meeting with the FDA,” commented Lexaria Chair and CEO Chris Bunka. “Catherine’s practical development and regulatory expertise will be of increasing value to Lexaria, and we look forward to working with her.” The onboarding of Dr. Turkel comes on the heels of a Pre-IND meeting regarding Lexaria’s DehydraTECH-CBD for the treatment of hypertension. Reporting that the meeting had yielded positive feedback from the FDA, the company’s August 10 announcement noted that the FDA had seconded its proposal to pursue an abbreviated regulatory pathway that would enable a faster route to commercial approval (https://ibn.fm/s6vqg). In addition, the FDA favorably received the company’s proposed Phase 1b clinical trial protocol that will involve ~100 patients with hypertension with the intention of opening the IND application to allow Lexaria to work toward full registration of its potential treatment. “As a result of the favorable FDA response, Lexaria expects to remain on track to file its full IND application with the FDA by late 2022/ early 2023, as previously announced. This is up to 6-9 months sooner than if the FDA had required modifications in Lexaria’s current IND-enabling work plan, such as performance of additional non-clinical study work,” the August 10 news release reads. Lexaria has shown, through human testing, that DehydraTECH-processed CBD delivers promising results with no serious adverse effects. In 2018, the company administered the substance to 12 participants in a human clinical study (“HCS”) that evidenced 317% more CBD delivered to the blood at 30 minutes than controls. Moreover, three HCSs conducted in 2021, HYPER-H21-1, HYPER-H21-2, and HYPER-H21-3, evidenced rapid and sustained drop in blood pressure, a 23% average drop in overnight blood pressure and reduced arterial stiffness, and attenuated pulmonary artery systolic pressure, respectively (https://ibn.fm/12iYb). For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• While traditional lenders remain reluctant to serve state-licensed cannabis industry prospects, REZYFi focuses on servicing the sector
• ResMac subsidiary expects to accumulate $285 million in retail origination and $250 million in wholesale origination in 2023
• The National Association of Realtors(R) reported one-third of surveyed agents experienced an increase in demand for warehouses, 28% in land demand, and 23% in demand for storefront property

REZYFi, a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses, is one of the first mortgage bankers of its kind in the United States, leveraging its position in a market where most traditional lenders remain diffident to serve the state-licensed cannabis industry. Through its two wholly owned subsidiaries – REZYFi Lending and ResMac Inc. – REZYFi is targeting licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financing. Through REZYFi Lending, the company is leveraging a wide network to offer multiple options, including 15- to 30-year fixed rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans, and adjustable-rate mortgages. The company expects increased funding in marketing and loan agents to drive significant growth in origination over the next two years, which is supported by the planned launch of a high-margin cannabis division later in 2022. In operation for 13 years, ResMac Inc. has closed more than 20,000 loans for more than 15,000 clients and expects to accumulate $285 million in retail origination and $250 million in wholesale origination in 2023. ResMac is also targeting $600 million in origination through its mortgage correspondent operations during the same period. The company intends to harvest the database of customers within its mortgage servicing operations as an essential source for expanding the new alternative residential loan programs it will operate. In an April 2021 report titled Marijuana and Real Estate: A Budding Issue, the National Association of Realtors(R) (“NAR”) examines the impact that cannabis legalization has on the real estate industry. In states where prescription and recreational cannabis use is legal, more than one-third of the agents surveyed reported an increase in demand for warehouses, 28% observed increases in land demand, and 23% reported increases for storefront property (https://ibn.fm/0C3WE). REZYFi is demonstrating its corporate strengths within the market through experience, a network of independent brokers, and proprietary technology through both subsidiaries. The company is led by a seasoned management team with over 40 years of combined experience in the mortgage and lending industry, as well as experience in the cannabis and hemp marketplace. Over the past five years, REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers – with training that has already commenced for network members to familiarize them with the company’s new service offerings. Through its proprietary automated/machine learning technology, REZYFi shortens loan processing timeframes and increases efficiencies, allowing it to operate its legacy business at staffing levels meaningfully below its competition. For more information, visit the company’s website at www.REZYFi.com. NOTE TO INVESTORS: The latest news and updates relating to REZYFi are available in the company’s newsroom at https://ibn.fm/REZY